Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Hepatitis C virus core protein subverts the antiviral activities of human Kupffer cells.

Tu Z, Pierce RH, Kurtis J, Kuroki Y, Crispe IN, Orloff MS.

Gastroenterology. 2010 Jan;138(1):305-14. doi: 10.1053/j.gastro.2009.09.009. Epub 2009 Sep 19.

PMID:
19769973
2.

Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.

Wu J, Meng Z, Jiang M, Zhang E, Trippler M, Broering R, Bucchi A, Krux F, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M, Schlaak JF.

Immunology. 2010 Mar;129(3):363-74. doi: 10.1111/j.1365-2567.2009.03179.x. Epub 2009 Nov 16.

3.

Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.

Chang S, Dolganiuc A, Szabo G.

J Leukoc Biol. 2007 Sep;82(3):479-87. Epub 2007 Jun 26.

PMID:
17595379
4.

IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.

Sirén J, Pirhonen J, Julkunen I, Matikainen S.

J Immunol. 2005 Feb 15;174(4):1932-7.

5.

Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.

Broering R, Wu J, Meng Z, Hilgard P, Lu M, Trippler M, Szczeponek A, Gerken G, Schlaak JF.

J Hepatol. 2008 Jun;48(6):914-22. doi: 10.1016/j.jhep.2008.01.028. Epub 2008 Mar 3.

PMID:
18362039
6.

Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.

Jung YO, Cho ML, Lee SY, Oh HJ, Park JS, Park MK, Park MJ, Ju JH, Kim SI, Park SH, Kim HY, Min JK.

Immunol Lett. 2009 Apr 27;123(2):138-43. doi: 10.1016/j.imlet.2009.03.004. Epub 2009 Mar 21.

PMID:
19428561
7.

Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.

Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD.

J Allergy Clin Immunol. 2004 Jul;114(1):174-82.

PMID:
15241362
8.

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.

Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G.

Gastroenterology. 2004 Nov;127(5):1513-24.

PMID:
15521019
9.

Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signaling in astrocytes.

Borysiewicz E, Fil D, Konat GW.

J Neurosci Res. 2009 May 15;87(7):1565-72. doi: 10.1002/jnr.21968.

PMID:
19115402
10.

Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2.

Chung H, Watanabe T, Kudo M, Chiba T.

J Infect Dis. 2010 Sep 15;202(6):853-61. doi: 10.1086/655812.

PMID:
20677943
11.

Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.

Vanhoutte F, Paget C, Breuilh L, Fontaine J, Vendeville C, Goriely S, Ryffel B, Faveeuw C, Trottein F.

Immunol Lett. 2008 Feb 15;116(1):86-94. doi: 10.1016/j.imlet.2007.11.014. Epub 2007 Dec 17.

PMID:
18166232
12.

Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.

Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R, Chung KF.

J Allergy Clin Immunol. 2006 Sep;118(3):641-8. Epub 2006 Jul 3.

PMID:
16950283
13.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
14.

Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.

Miyazaki M, Kanto T, Inoue M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kakita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N.

J Med Virol. 2008 Jun;80(6):980-8. doi: 10.1002/jmv.21174.

PMID:
18428149
15.

Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses.

McDonald DR, Brown D, Bonilla FA, Geha RS.

J Allergy Clin Immunol. 2006 Dec;118(6):1357-62. Epub 2006 Sep 25.

PMID:
17157666
16.

Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis.

Takii Y, Nakamura M, Ito M, Yokoyama T, Komori A, Shimizu-Yoshida Y, Nakao R, Kusumoto K, Nagaoka S, Yano K, Abiru S, Ueki T, Matsumoto T, Daikoku M, Taniguchi K, Fujioka H, Migita K, Yatsuhashi H, Nakashima M, Harada M, Ishibashi H.

Lab Invest. 2005 Jul;85(7):908-20.

17.

CC chemokine ligand 17 in periodontal diseases: expression in diseased tissues and production by human gingival fibroblasts.

Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T.

J Periodontal Res. 2008 Aug;43(4):471-7. doi: 10.1111/j.1600-0765.2007.01080.x.

PMID:
18557811
18.

Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.

Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, Crawford JM, Nelson DR, Liu C.

Gastroenterology. 2007 Nov;133(5):1649-59. Epub 2007 Sep 16.

PMID:
17983809
19.

Supplemental Content

Support Center